To evaluate the therapeutic efficacy of these hit JAK inhibitors in vivo, we tested 10 inhibitors, which cover JAK1, 2, and 3 and have better anti-inflammatory properties (bold in Table 1, and the structures shown in Fig. 1), in a mouse influenza model. Here, JAK1 is linked to influenza.